Zymeworks (ZYME) Shares Outstanding (2021 - 2026)

Zymeworks has reported Shares Outstanding (Entity) for 6 years, with the latest figure at $73.1 million in Q1 2026.

• Quarterly Shares Outstanding (Entity) rose 5.06% year-over-year to $73.1 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $73.1 million (up 5.06% YoY) and the FY2025 annual result came in at $74.6 million, up 8.23% from the prior year.
• Shares Outstanding (Entity) retreated to $73.1 million in Q1 2026 per ZYME's latest filing, from $74.6 million in the prior quarter.
• Over five years, Shares Outstanding (Entity) peaked at $75.1 million in Q3 2025 and troughed at $57.8 million in Q1 2022.
• A 5-year average of $68.1 million and a median of $69.6 million in 2025 frame the typical range for Shares Outstanding (Entity).
• The sharpest annual moves came in 2022 and 2024: Shares Outstanding (Entity) surged 35.22% in 2022, then dropped 1.64% in 2024.
• Over 5 years, Shares Outstanding (Entity) stood at $63.1 million in 2022, then rose by 11.19% to $70.1 million in 2023, then fell by 1.64% to $69.0 million in 2024, then climbed by 8.23% to $74.6 million in 2025, then dropped by 2.06% to $73.1 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $73.1 million, $74.6 million, and $75.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.